Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. announced earnings results for the first quarter ended March 31, 2020. For the first quarter, the company announced sales was CNY 34.716 million compared to CNY 83.560 million a year ago. Operating loss was CNY 22.635 million compared to CNY 113,100.000000 a year ago. Net loss was CNY 18.286 million compared to net income of CNY 4.902 million a year ago.